Psylo

0 followers
‌

Psylo is a drug development company that focuses on next-generation psychedelics. With psychedelic molecules as the starting point, our goal is to develop medicines that are widely available as improved treatments to currently available SSRI medications.

Industries

Headquarters

Sydney, Australia

Employees

11-50

Links


Org chart

🧪 Joshua Ismin
Co-founder, CEO
Collapse
Lawrence P. (Larry) Wennogle, Ph.D.
Vice President Translational Research
William Jorgensen
Lead Medicinal Chemist
Donald Gehlert
Vice President, Translational Sciences

Teams

This company has no teams yet